MedCity News November 22, 2021
Sword Health, one of several companies looking to take a digital approach to musculoskeletal care, recently closed an oversubscribed $163 million series D round, giving it a $2 billion valuation.
Facing an increasingly competitive market for musculoskeletal care, Sword Health recently struck a $2 billion valuation after closing an oversubscribed series D round. The company originally sought out to raise $163 million in a round led by technology-focused VC firm Sapphire Ventures, but ended up bringing in $26 million more.
Sword is one of several digital health companies looking to provide virtual care for musculoskeletal conditions. To differentiate itself from competitors, it touts its physical therapists and the range of conditions that it covers beyond back pain.
Founder and CEO...